Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients

World Journal of Gastroenterology

Volumn 22, Issue 11, 2016, Pages 3227-3233

  Li, Yu Yuan ^a   Ge, Quan Xing ^a   Cao, Jie ^a   Zhou, Yong Jian ^a   Du, Yan Lei ^a   Shen, Bo ^a   Wan, Yu Jui Yvonne ^b   Nie, Yu Qiang ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colorectal cancer; Fluorescence in situ hybridization; Fluorescent quantitative polymerase chain reaction; Fusobacterium nucleatum; Metastases

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL DNA;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUSOBACTERIUM INFECTION; FUSOBACTERIUM NUCLEATUM; FUSOBACTERIUM NUCLEATUM INFECTION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CLASSIFICATION; COLORECTAL NEOPLASMS; FUSOBACTERIUM INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; RIBOTYPING; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COLORECTAL NEOPLASMS; DNA, BACTERIAL; FEMALE; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NUCLEATUM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RIBOTYPING; RISK FACTORS;

EID: 84960889352     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i11.3227     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90. [PMID: 21296855. DOI: 10.3322/caac.20107
2. Rowland IR. The role of the gastrointestinal microbiota in colorectal cancer. Curr Pharm Des 2009; 15: 1524-1527. [PMID: 19442169
3. Warren RL, Freeman DJ, Pleasance S, Watson P, Moore RA, Cochrane K, Allen-Vercoe E, Holt RA. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 2013; 1: 16. [PMID: 24450771. DOI: 10.1186/2049-2618-1-16
4. Parkin DM. The global health burden of infection-Associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-3044. [PMID: 16404738. DOI: 10.1002/ijc.21731
5. Han YW. Fusobacterium nucleatum: a commensal-Turned pathogen. Curr Opin Microbiol 2015; 23: 141-147. [PMID: 25576662. DOI: 10.1016/j.mib.2014.11.013
6. Flanagan L, Schmid J, Ebert M, Soucek P, Kunicka T, Liska V, Bruha J, Neary P, Dezeeuw N, Tommasino M, Jenab M, Prehn JH, Hughes DJ. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis 2014; 33: 1381-1390. [PMID: 24599709. DOI: 10.1007/s10096-014-2081-3
7. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306. [PMID: 22009989. DOI: 10.1101/gr.126516.111
8. Williams ST, Beart RW. Staging of colorectal cancer. Semin Surg Oncol 1992; 8: 89-93. [PMID: 1615269
9. Gaetti-Jardim E, Marcelino SL, Feitosa AC, Romito GA, Avila-Campos MJ. Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol 2009; 58: 1568-1575. [PMID: 19679682. DOI: 10.1099/jmm.0.013383-0
10. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, Garrett WS. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013; 14: 207-215. [PMID: 23954159. DOI: 10.1016/j.chom.2013.07.007
11. Gentili V, Gianesini S, Balboni PG, Menegatti E, Rotola A, Zuolo M, Caselli E, Zamboni P, Di Luca D. Panbacterial real-Time PCR to evaluate bacterial burden in chronic wounds treated with Cutimed™ Sorbact™. Eur J Clin Microbiol Infect Dis 2012; 31: 1523-1529. [PMID: 22113306. DOI: 10.1007/s10096-011-1473-x
12. Loy A, Arnold R, Tischler P, Rattei T, Wagner M, Horn M. probeCheck-A central resource for evaluating oligonucleotide probe coverage and specificity. Environ Microbiol 2008; 10: 2894-2898. [PMID: 18647333. DOI: 10.1111/j.1462-2920.2008.01706.x
13. Swidsinski A, Dörffel Y, Loening-Baucke V, Theissig F, Rückert JC, Ismail M, Rau WA, Gaschler D, Weizenegger M, Kühn S, Schilling J, Dörffel WV. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 2011; 60: 34-40. [PMID: 19926616. DOI: 10.1136/gut.2009.191320
14. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489: 242-249. [PMID: 22972297. DOI: 10.1038/nature11552
15. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904. [PMID: 20664075. DOI: 10.1152/physrev.00045.2009
16. Bustos Fernandez LM, Lasa JS, Man F. Intestinal microbiota: its role in digestive diseases. J Clin Gastroenterol 2014; 48: 657-666. [PMID: 24921207. DOI: 10.1097/MCG.0000000000000153
17. Allen-Vercoe E, Jobin C. Fusobacterium and Enterobacteriaceae: important players for CRC? Immunol Lett 2014; 162: 54-61. [PMID: 24972311. DOI: 10.1016/j.imlet.2014.05.014
18. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22: 292-298. [PMID: 22009990. DOI: 10.1101/gr.126573.111
19. Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN, Jenkins N, Jovov B, Abdo Z, Sandler RS, Keku TO. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010; 1: 138-147. [PMID: 20740058. DOI: 10.4161/gmic.1.3.12360
20. McCoy AN, Araújo-Pérez F, Azcárate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS One 2013; 8: e53653. [PMID: 23335968
21. Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, Kostic AD, Giannakis M, Bullman S, Milner DA, Baba H, Giovannucci EL, Garraway LA, Freeman GJ, Dranoff G, Garrett WS, Huttenhower C, Meyerson M, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 2015; Epub ahead of print. [PMID: 26311717. DOI: 10.1136/gutjnl-2015-310101
22. Ito M, Kanno S, Nosho K, Sukawa Y, Mitsuhashi K, Kurihara H, Igarashi H, Takahashi T, Tachibana M, Takahashi H, Yoshii S, Takenouchi T, Hasegawa T, Okita K, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y. Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway. Int J Cancer 2015; 137: 1258-1268. [PMID: 25703934. DOI: 10.1002/ijc.29488
23. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-Associated microbiota in patients with colorectal cancer. PLoS One 2012; 7: e39743. [PMID: 22761885
24. Sonnenburg JL, Angenent LT, Gordon JI. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat Immunol 2004; 5: 569-573. [PMID: 15164016. DOI: 10.1038/ni1079
25. Oswald IP. Role of intestinal epithelial cells in the innate immune defence of the pig intestine. Vet Res 2006; 37: 359-368. [PMID: 16611553
26. Strauss J, White A, Ambrose C, McDonald J, Allen-Vercoe E. Phenotypic and genotypic analyses of clinical Fusobacterium nucleatum and Fusobacterium periodonticum isolates from the human gut. Anaerobe 2008; 14: 301-309. [PMID: 19114111. DOI: 10.1016/j.anaerobe.2008.12.003
27. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 2013; 14: 195-206. [PMID: 23954158. DOI: 10.1016/j.chom.2013.07.012
28. Tahara T, Yamamoto E, Suzuki H, Maruyama R, Chung W, Garriga J, Jelinek J, Yamano HO, Sugai T, An B, Shureiqi I, Toyota M, Kondo Y, Estécio MR, Issa JP. Fusobacterium in colonic flora and molecular features of colorectal carcinoma. Cancer Res 2014; 74: 1311-1318. [PMID: 24385213. DOI: 10.1158/0008-5472.CAN-13-1865
29. Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, Inamura K, Kim SA, Masuda A, Nowak JA, Nosho K, Kostic AD, Giannakis M, Watanabe H, Bullman S, Milner DA, Harris CC, Giovannucci E, Garraway LA, Freeman GJ, Dranoff G, Chan AT, Garrett WS, Huttenhower C, Fuchs CS, Ogino S. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol 2015; 1: 653-661. [PMID: 26181352. DOI: 10.1001/jamaoncol.2015.1377
30. Bashir A, Miskeen AY, Bhat A, Fazili KM, Ganai BA. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis. Eur J Cancer Prev 2015; 24: 373-385. [PMID: 25569450. DOI: 10.1097/CEJ.0000000000000116
31. Viljoen KS, Dakshinamurthy A, Goldberg P, Blackburn JM. Quantitative profiling of colorectal cancer-Associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer. PLoS One 2015; 10: e0119462. [PMID: 25751261 10.1371/journal.pone.0119462
32. Colussi D, Brandi G, Bazzoli F, Ricciardiello L. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci 2013; 14: 16365-16385. [PMID: 23965959. DOI: 10.3390/ijms140816365
33. Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers (Basel) 2013; 5: 676-713. [PMID: 24216997. DOI: 10.3390/cancers5020676
34. Zoratto F, Rossi L, Verrico M, Papa A, Basso E, Zullo A, Tomao L, Romiti A, Lo Russo G, Tomao S. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis. Tumour Biol 2014; 35: 6195-6206. [PMID: 25051912. DOI: 10.1007/s13277-014-1845-9
35. Bishehsari F, Mahdavinia M, Vacca M, Malekzadeh R, Mariani-Costantini R. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol 2014; 20: 6055-6072. [PMID: 24876728. DOI: 10.3748/wjg.v20.i20.6055
36. Ogino S, Chan AT, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011; 60: 397-411. [PMID: 21036793. DOI: 10.1136/gut.2010.217182
37. Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol 2013; 26: 465-484. [PMID: 23307060. DOI: 10.1038/modpathol.2012.214